CN114344372B - Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof - Google Patents

Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof Download PDF

Info

Publication number
CN114344372B
CN114344372B CN202210004632.XA CN202210004632A CN114344372B CN 114344372 B CN114344372 B CN 114344372B CN 202210004632 A CN202210004632 A CN 202210004632A CN 114344372 B CN114344372 B CN 114344372B
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
liver cancer
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210004632.XA
Other languages
Chinese (zh)
Other versions
CN114344372A (en
Inventor
李作伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202210004632.XA priority Critical patent/CN114344372B/en
Publication of CN114344372A publication Critical patent/CN114344372A/en
Application granted granted Critical
Publication of CN114344372B publication Critical patent/CN114344372B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating primary liver cancer, which is prepared by decocting senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati in water, and has the obvious effects of quick response, good curative effect, small side effect and obvious inhibition effect on tumors.

Description

Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof
Technical Field
The invention belongs to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating primary liver cancer.
Technical Field
Primary liver cancer, abbreviated as liver cancer, usually occurs in hepatocytes or intrahepatic bile duct epithelial cells, which is one of the common malignant tumors in our country. Typical symptoms and signs of the liver cancer are usually in middle and late stages, and symptoms such as hypochondriac pain, hypodynamia, emaciation, jaundice, ascites and the like are mainly caused, on one hand, cancer pain accompanied by liver cancer is caused by that liver capsule is easily pulled to cause pain due to infiltration of liver cancer cells, and along with further development of cancer, adjacent blood vessels, peripheral nerves, lymphatic vessels, soft tissues and the like of the liver are sequentially invaded, pressed or stimulated by the liver cancer cells, so that the pain of the body and the mind is aggravated; at present, the three-step drug analgesic method recommended by WHO is generally adopted, and although pain can be relieved to a certain extent, adverse reactions caused by long-term use of the analgesic are large, so that the application process is also limited to different degrees.
In the latest diagnosis and treatment standard of primary liver cancer (2019 edition), the advantages of the traditional Chinese medicine, such as good curative effect and improvement of life quality, in the aspect of preventing and treating tumor diseases are pointed out, and the traditional Chinese medicine has become one of important means for treating liver cancer. On the basis, it is one direction of current research to find a traditional Chinese medicine composition which has the advantages of quick response, good curative effect, small side effect and obvious inhibition effect on tumors.
The invention comprises the following steps:
aiming at the defects of the prior art, the invention provides a traditional Chinese medicine composition for treating primary liver cancer, which has the obvious effects of quick response, good curative effect, small side effect and obvious inhibition effect on tumors.
The specific technical scheme of the invention is realized as follows:
a traditional Chinese medicine composition for treating primary liver cancer consists of the following components in parts by weight: 30-50 parts of senecio scandens, 20-40 parts of white snake grass, 10-30 parts of ground grass, 10-30 parts of Japanese ardisia herb, 10-30 parts of cortex albiziae, 10-30 parts of fevervine, 10-30 parts of radix bupleuri, 10-30 parts of dried orange peel and 20-40 parts of semen astragali complanati.
Preferably, the traditional Chinese medicine composition for treating primary liver cancer comprises the following components in parts by weight: 40-50 parts of senecio scandens, 30-40 parts of white snake grass, 20-30 parts of ground grass, 25-30 parts of Japanese ardisia herb, 10-15 parts of cortex albiziae, 10-20 parts of fevervine, 10-15 parts of radix bupleuri, 10-20 parts of dried orange peel and 20-30 parts of semen astragali complanati.
Preferably, the traditional Chinese medicine composition for treating primary liver cancer comprises the following components in parts by weight: 50 parts of senecio scandens, 40 parts of white snake grass, 30 parts of ground grass, 30 parts of Japanese ardisia herb, 10 parts of cortex albiziae, 10 parts of fevervine, 25 parts of radix bupleuri, 15 parts of dried orange peel and 20 parts of semen astragali complanati.
In the formulation, the composition may be in the form of a gel,
herba Senecionis Scandentis, bitter and cold; enter lung and liver meridians; clear away heat and toxic materials, improve eyesight, and promote diuresis. The main indications are: carbuncle, sore, cold, fever, conjunctival congestion, swelling and pain, diarrhea, dysentery and skin eczema.
White snake grass is cool in nature and slightly bitter and sweet in taste; enter stomach meridian, large intestine meridian and small intestine meridian. Clearing heat, promoting diuresis, removing toxic substances, and resisting cancer.
Di Yu Cao is cool in nature, sweet and slightly bitter in flavor. Enter liver meridian, gallbladder meridian and large intestine meridian. Clearing heat and promoting diuresis, removing toxic substance, removing blood stasis and detumescence, and relieving pain.
Herba Ardisiae Japonicae is neutral in nature, bitter and pungent in flavor. Enter lung meridian and liver meridian. Relieving cough, eliminating phlegm, promoting blood circulation, promoting urination, and removing toxic substances.
Albizzia bark, cortex Albizziae, has flat property and sweet taste. It enters heart meridian, liver meridian and lung meridian. Resolving stagnation, tranquillizing, promoting blood circulation and detumescence.
Paederia scandens is neutral in nature, sweet and bitter in taste. It enters spleen meridian, stomach meridian, liver meridian and lung meridian. Dispelling pathogenic wind, promoting blood circulation, relieving pain, removing toxic substance, resolving food stagnation, removing dampness, and relieving swelling.
Chai Hu is slightly cold in nature and bitter in taste. It enters liver meridian, gallbladder meridian and lung meridian. Relieving exterior and interior syndrome, soothing liver, and elevating yang.
Chen Pi is pungent in flavor, bitter in flavor and warm in nature. Enter spleen meridian and lung meridian. Regulating qi-flowing, stimulating appetite, eliminating dampness and resolving phlegm, and treating spleen and stomach diseases.
Semen astragali Complanati is warm in nature and sweet in taste. Enter liver meridian and kidney meridian. Warming and nourishing liver and kidney, securing essence, reducing urination and improving eyesight.
In the present invention: the senecio scandens, the white snake grass and the hypericum japonicum are monarch drugs for clearing heat and detoxicating; herba Ardisiae Japonicae, cortex Albiziae, herba Paederiae, and has effects of promoting blood circulation and removing blood stasis, and can be used as ministerial drug; bupleurum, dried orange peel and semen astragali complanati are used as adjuvant drugs for soothing liver, invigorating yang, strengthening spleen and tonifying kidney and harmonizing various drugs. The medicines are combined to play the roles of strengthening body resistance, eliminating evil and balancing yin and yang. Therefore, the traditional Chinese medicine can inhibit the growth of tumors, and obviously improve the symptoms of fever, tumor enlargement and the like of tumor patients, thereby achieving the effect of inhibiting the tumors.
The method for preparing the traditional Chinese medicine composition for treating primary liver cancer comprises the following steps:
weighing the prescription amount of senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati; adding 5-10 times of water, decocting until one fifth of water is left, and filtering to obtain decoction.
The administration method of the medicine soup comprises the following steps: the adult can take 500ml each time three times a day.
The traditional Chinese medicine composition for treating the primary liver cancer adopts dialectical theory to screen the traditional Chinese medicine composition, and the provided traditional Chinese medicine composition has the advantages of quick response, good curative effect, small side effect and obvious inhibition effect on primary tumors. The decoction is simple to prepare, convenient to take clinically, safe to use and high in operability.
Drawings
FIG. 1 is a time-tumor volume plot;
fig. 2 is a time-tumor weight plot.
Detailed Description
Example 1
The traditional Chinese medicine composition for treating primary liver cancer comprises the following components in parts by weight: 50 parts of senecio scandens, 40 parts of white snake grass, 30 parts of ground grass, 30 parts of Japanese ardisia herb, 10 parts of cortex albiziae, 10 parts of fevervine, 25 parts of radix bupleuri, 15 parts of dried orange peel and 20 parts of semen astragali complanati.
Weighing the prescription amount of senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati; adding 5-10 times of water, decocting until one fifth of water is left, and filtering to obtain decoction;
the administration method of the medicine soup comprises the following steps: the adult can take 500ml each time three times a day.
Example 2
The traditional Chinese medicine composition for treating primary liver cancer comprises the following components in parts by weight: 30 parts of senecio scandens, 20 parts of white snake grass, 10 parts of ground otope herb, 10 parts of Japanese ardisia herb, 10 parts of cortex albiziae, 10 parts of fevervine, 10 parts of radix bupleuri, 10 parts of dried orange peel and 25 parts of semen astragali complanati.
Weighing the prescription amount of senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati; adding 5-10 times of water, decocting until one fifth of water is left, and filtering to obtain decoction;
the administration method of the medicine soup comprises the following steps: the adult can take 500ml each time three times a day.
Example 3
The traditional Chinese medicine composition for treating primary liver cancer comprises the following components in parts by weight: 45 parts of senecio scandens, 35 parts of white snake grass, 25 parts of ground grass, 25 parts of Japanese ardisia herb, 15 parts of cortex albiziae, 20 parts of fevervine, 15 parts of radix bupleuri, 20 parts of dried orange peel and 30 parts of semen astragali complanati.
Weighing the prescription amount of senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati; adding 5-10 times of water, decocting until one fifth of water is left, and filtering to obtain decoction;
the administration method of the medicine soup comprises the following steps: the adult can take 500ml each time three times a day.
Example 4
The traditional Chinese medicine composition for treating primary liver cancer comprises the following components in parts by weight: 40 parts of senecio scandens, 30 parts of white snake grass, 20 parts of ground grass, 20 parts of Japanese ardisia herb, 12 parts of cortex albiziae, 30 parts of fevervine, 30 parts of radix bupleuri, 30 parts of dried orange peel and 40 parts of semen astragali complanati;
weighing the prescription amount of senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati; adding 5-10 times of water, decocting until one fifth of water is left, and filtering to obtain decoction;
the administration method of the medicine soup comprises the following steps: the adult can take 500ml each time three times a day.
Test examples
1. Preparing a mouse liver cancer model, and testing whether the mouse liver cancer model has the effect of reducing the tumor volume and the tumor weight
(1) After passage of tumor strain through Kunming mouse for 6d, cervical dislocation is treated to kill the mouse, the milky ascites of the mouse is aseptically taken, and diluted into tumor cell suspension with sterile physiological saline according to a ratio of 1:3.5; the tumor cell suspension is extracted, and 0.2 ml/mouse is inoculated under the skin of the armpit of the right forelimb after conventional disinfection, so that an animal model of solid tumor is prepared.
(2) Weighing after inoculation, dividing the mice into 2 groups according to Latin method, wherein each group comprises 10 mice, namely (1) a control group (2) a dosing group; the formulation described in example 1 was administered to the lavage at 13.5g/kg (0.2 ml/10 g) and the control group was administered the same volume of potable water; the body weight of the mice was measured at the beginning and end of the experiment, respectively, and attention was paid to observing the general condition of the mice.
(3) The method comprises the steps of weighing the volume of a mouse every day, weighing the mouse after stopping taking the medicine, killing the mouse after cervical dislocation, forceps the skin of the growing part of the right armpit tumor of the mouse, then cutting the skin by using a surgical scissors, exposing the tumor, blunt peeling the tumor by using the surgical scissors, and weighing the tumor by using an electronic balance. The specific time-tumor volume and time-tumor weight effect are shown in fig. 1 and 2, and it can be seen from fig. 1 and 2 that the tumor volume and tumor weight are obviously reduced after 6 weeks with the lapse of the administration time, which shows that the decoction has the effect of inhibiting the growth of tumor.
2. Clinical efficacy study
(1) 200 patients with primary liver cancer which are clinically diagnosed are randomly selected, and the patients are mainly characterized by liver pain, anorexia, debilitation, emaciation, abdominal mass, limb weakness, dyspepsia, nausea, abdominal distention, anemia, ascites, edema, jaundice and the like, and liver tumors are visible in CT examination.
(2) The administration method comprises the following steps:
the adult can take 500ml each time three times a day.
(3) Curative effect: effective (symptoms are improved, cancer focus is reduced by more than half, and other objective examination is obviously improved); ineffective (no improvement in symptoms or objective examination). The specific clinical effects are shown in Table 1.
TABLE 1 clinical effects of primary liver cancer treatment
Figure BDA0003455084160000041
Figure BDA0003455084160000051
Clinical experiments prove that the total effective rate of the traditional Chinese medicine formula provided by the invention on primary liver cancer is 90%, wherein the traditional Chinese medicine formula disclosed by the embodiment 1 has the best effect, and the traditional Chinese medicine formula can obviously reduce the tumor area and weight after being taken for more than half a year.
Treatment of cancer examples:
1. plum XX, woman, 72 years old, shandong, liver pain, anorexia, debilitation, CT examination in hospital at 2018 at 7 month and 3 days, liver cancer diagnosis, 5cm x 6cm tumor, taking the decoction for more than 2 months, and checking to reduce tumor to 2cm x 3cm.
2. Zhao XX, male, 68 years old, shandong, anorexia, abdominal distention, nausea, CT in hospital at 10 month 9 of 2019, puncture pathological examination, liver cancer, tumor of 8cm x 9cm, taking the decoction for more than 3 months, and checking to reduce tumor to 6cm x 7cm.
3. Grand XX, male, 70 years old, shandong, vomiting, diarrhea, abdominal distention, and in hospital PETCT at 30 days of 2020, pathologically diagnosed liver cancer, 6cm x 7cm tumor, taking the decoction for more than 5 months, and checking to reduce tumor to 3cm x 3cm.
The above examples demonstrate that: the traditional Chinese medicine composition has the effects of strengthening body resistance to eliminate pathogenic factors and balancing yin and yang, can inhibit the growth of tumors, and can obviously improve the symptoms of fever, tumor enlargement and the like of tumor patients, thereby achieving the effect of inhibiting the tumors.

Claims (4)

1. A traditional Chinese medicine composition for treating primary liver cancer is characterized in that: the composite material consists of the following components in parts by weight: 30-50 parts of senecio scandens, 20-40 parts of white snake grass, 10-30 parts of ground grass, 10-30 parts of Japanese ardisia herb, 10-30 parts of cortex albiziae, 10-30 parts of fevervine, 10-30 parts of radix bupleuri, 10-30 parts of dried orange peel and 20-40 parts of semen astragali complanati;
weighing the prescription amount of senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati; adding 5-10 times of water, decocting until one fifth of water is left, and filtering to obtain decoction;
the administration method of the medicine soup comprises the following steps: the adult can take 500ml each time three times a day.
2. The traditional Chinese medicine composition for treating primary liver cancer according to claim 1, which is characterized in that: the composite material consists of the following components in parts by weight: 40-50 parts of senecio scandens, 30-40 parts of white snake grass, 20-30 parts of ground grass, 25-30 parts of Japanese ardisia herb, 10-15 parts of cortex albiziae, 10-20 parts of fevervine, 10-15 parts of radix bupleuri, 10-20 parts of dried orange peel and 20-30 parts of semen astragali complanati.
3. The traditional Chinese medicine composition for treating primary liver cancer according to claim 1, which is characterized in that: the composite material consists of the following components in parts by weight: 50 parts of senecio scandens, 40 parts of white snake grass, 30 parts of ground grass, 30 parts of Japanese ardisia herb, 10 parts of cortex albiziae, 10 parts of fevervine, 25 parts of radix bupleuri, 15 parts of dried orange peel and 20 parts of semen astragali complanati.
4. A method for preparing the traditional Chinese medicine composition according to claims 1-3, characterized in that: weighing the prescription amount of senecio scandens, white snake grass, hypericum japonicum, japanese ardisia herb, cortex albiziae, fevervine, radix bupleuri, dried orange peel and semen astragali complanati; adding 5-10 times of water, decocting until one fifth of water is left, and filtering to obtain decoction;
the administration method of the medicine soup comprises the following steps: the adult can take 500ml each time three times a day.
CN202210004632.XA 2022-01-04 2022-01-04 Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof Active CN114344372B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210004632.XA CN114344372B (en) 2022-01-04 2022-01-04 Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210004632.XA CN114344372B (en) 2022-01-04 2022-01-04 Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114344372A CN114344372A (en) 2022-04-15
CN114344372B true CN114344372B (en) 2023-04-25

Family

ID=81106697

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210004632.XA Active CN114344372B (en) 2022-01-04 2022-01-04 Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114344372B (en)

Also Published As

Publication number Publication date
CN114344372A (en) 2022-04-15

Similar Documents

Publication Publication Date Title
CN103751310B (en) A kind of traditional Chinese medicine for external application and its preparation method treating fascitis
CN102657739A (en) Eyesight adjusting ointment for myopia
CN101537107A (en) External use liniment capable of treating dermatomycosis and preparation method thereof
CN104288701A (en) Traditional Chinese medicine composition for treating cholecystitis
CN105213941A (en) A kind of Chinese medicine composition being used for the treatment of infantile diarrhea and preparation method thereof
CN109432269A (en) A kind of Chinese medicine composition and preparation method, purposes
CN1709302A (en) Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method
CN112022916A (en) Traditional Chinese medicine composition and preparation for treating postpartum body pain and preparation method and application thereof
CN114344372B (en) Traditional Chinese medicine composition for treating primary liver cancer and preparation method thereof
CN105213889A (en) One treats prostatitic Chinese medicine oral liquid and preparation method
CN109464517A (en) Clearing heat and detoxicating paediatrics external application massage ointment formula, the method and application for preparing ointment
CN102872362A (en) Traditional Chinese medicine for treating chronic cholecystitis
CN104352737A (en) Traditional Chinese medicinal preparation for treating rheumatic low back and leg pain
CN110812463A (en) Traditional Chinese medicine enema for treating pelvic inflammation and preparation method thereof
CN111202833A (en) Constant-temperature long-acting spontaneous heating plaster for treating osteoarthritis
CN110478416A (en) The composition and its preparation method and application for treating rheumatic rheumatoid arthritis
CN104524124A (en) Traditional Chinese medicinal preparation for treating skull osteomyelitis and preparation method
CN103845547A (en) Traditional Chinese medicine decoction for treating mumps
CN103830679B (en) A kind of medicine and application thereof for the treatment of irritable bowel syndrome
CN103495119B (en) Medicament for treating qi stagnation and blood stasis chronic prostatitis
CN114748580A (en) Miao medicine for treating bladder cancer and preparation method thereof
CN104623127A (en) Medicine for treating tinea pedis and preparation method thereof
CN104644907A (en) Traditional Chinese medicine formula for treating chronic pelvic inflammatory disease
CN105055622B (en) A kind of Chinese medicine film-forming gel agent treating either shallow bed sore at ulcerative stage
CN104873902A (en) Traditional Chinese medicine emplastrum for treating wounds and bone diseases

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant